研究领域

高永娥，理学博士，山西吕梁人。2015年7月于山西大同大学获得学士学位；2015年9月至2018年6月，西南大学材料与能源学院攻读硕士学位，从事聚合物基纳米药物载体的构建及抗肿瘤性能研究；2018年9月至2021年6月，西南大学化学化工学院攻读博士学位，研究蚕丝蛋白纳米药物的抗肿瘤性能。迄今为止，在ACS Sustainable Chem. Eng.、Colloids Surf., B等国际研究刊物发表SCI论文4篇。

论文与著作

科研项目

1.酸响应丝素纳米药物的制备及抗肿瘤性能研究，山西省科技厅青年项目（202103021223363），4万元，2022/01-2024/12，主持，在研。

发表论文

1. Yong-E Gao, Shengxin Hou, JiaqiCheng, Xinyi Li, Yongqiong Wu, YuranTang, Yanke Li, Peng Xue, Yuejun Kang, Zhigang Xu*, Mingming Guo*. SilkSericin-Based Nanoparticle as the Photosensitizer Chlorin e6 Carrier forEnhanced Cancer Photodynamic Therapy. ACS SustainableChemistry&Engineering, 2021, 9 (8), 3213-3222.

2. Yong-E Gao, Shuang Bai, Xiaoqian Ma, Xiaoli Zhang, MeiliHou, Xiaoxiao Shi, Xiaohua Huang, Jiucun Chen, Feiqiu Wen*, Peng Xue, Yuejun Kang,Zhigang Xu*.Codelivery of doxorubicin and camptothecin by dual-responsive unimolecularmicelle-based β-cyclodextrin for enhanced chemotherapy.Colloids and Surfaces B:Biointerfaces, 2019, 183, 110428.

3. Yong-E Gao, Shuang Bai, Xiaoxiao Shi, Meili Hou, Xiaoqian Ma, Zhang, Tian; Xiao, Bo; Peng Xue, Yuejun Kang,Zhigang Xu*. Irinotecan delivery by unimolecular micelles composed of reductionresponsive star-like polymeric prodrug with high drug loading forenhancedcancer therapy. Colloids and Surfaces B:Biointerfaces, 2018, 170, 488–496.

4.Yong-E Gao; Xiaoqian Ma, MeiliHou, Shuang Bai, Peng Xue, Yuejun Kang*,Zhigan Xu*.Highly cell-penetrating and ultra-pH-responsive nanoplatform for controlleddrug release and enhanced tumor therapy. Colloids and Surfaces B: Biointerfaces,2017, 159: 484-492.

5. Shengxin Hou, Yong-E Gao,Xianbin Ma, Yi Lu, Xinyi Li, Jiaqi Cheng, Yongqiong Wu, Peng Xue, Yuejun Kang, Mingming Guo*, Xu Zhigang*. TumorMicroenvironment Responsive Biomimetic Copper Peroxide Nanoreactors for DrugDelivery and Enhanced Chemodynamic Therapy. Chemical Engineering Journal, 2021, 416, 129037.